Skip to content

The effect of rTMS combined with repeated magnetic stimulation of Taichong (LR3) on depression: a randomized controlled trial

The effect of rTMS combined with repeated magnetic stimulation of Taichong (LR3) on depression: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027443
Enrollment
Unknown
Registered
2019-11-13
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Sponsors

Shaanxi Provincial Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent voluntarily; 2. Meet the western medicine diagnosis standard of depression; 3. It conforms to the diagnostic standard of depression in traditional Chinese medicine; 4. Hamilton Depression Scale 7 < HAMD-17 <= 24; 5. Aged 18-65 years old.

Exclusion criteria

Exclusion criteria: 1. Those diagnosed as other mental diseases, such as panic disorder, obsessive-compulsive disorder, schizophrenia, hypochondriasis, etc; 2. The patients who had used western medicine of anti anxiety, anti depression, anti psychosis and the same kind of traditional Chinese medicine in the first 4 weeks before entering the group; 3. Taking antidepressants or having antidepressant pharmacological effect without washout; 4. Pregnant or preparing pregnant or lactating women; 5. Hyperthyroidism, coronary heart disease, hypertension, irritable bowel syndrome and other endocrine, cardiovascular and digestive system diseases with depression; 6. Patients with organic mental disorders, psychoactive substances, non addictive substances and postpartum depression; 7. Patients who have a history of suicide or a tendency to commit suicide, with a suicide score >= 1 in HAMD-17; 8. Patients who participated in or are participating in other clinical trials within 1 month before enrollment; 9. Magnetic metal objects implanted near the head or in the brain, such as intracranial stent, cochlear implant, etc; 10. No monitoring or failure to complete the clinical study.

Design outcomes

Primary

MeasureTime frame
HAMD-17;SCL-90;PHQ-15;

Secondary

MeasureTime frame
PSQI;rMT;

Countries

China

Contacts

Public ContactLei Yaling

Shaanxi Provincial Chinese Medicine Hospital

ia678@qq.com+86 13032987128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026